|
| Â Â |
| Â | MedlinePlus Drug Information: Abciximab (Systemic) |
 | | Abciximab is used with aspirin and heparin, which are other medicines used to keep your blood from clotting. | | | If you have had abciximab before, you may have developed an allergy to it. | | | Children— Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of abciximab in children with use in other age groups. |
|
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500417.html
|
|
| Â Â |
| Â | American Family Physician: Abciximab and long-term protection from restenosis - Tips from Other Journals |
| | Another revascularization procedure was needed in 34.8 percent of the patients who received abciximab bolus plus infusion, compared with 38.6 percent of those who received abciximab bolus only and 40.1 percent of those who received placebo only. | | | Myocardial infarction occurred in 10.7 percent of the study subjects receiving abciximab bolus plus infusion, in 12.2 percent of those receiving abciximab bolus plus placebo, and in 13.6 percent of those receiving placebo. | | | Percutaneous coronary procedures are frequently followed by the need for repeat procedures or bypass surgery for coronary artery renarrowing. |
|
http://www.findarticles.com/cf_dls/m3225/n5_v57/20460476/p1/article.jhtml
|
|
| Â Â |
| Â | Abciximab Improves Myocardial Reperfusion - Journal Watch Cardiology |
| | Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction: Observations from the TIMI 14 trial. | | | This suggests that combination therapy may improve clinical outcome even more than would be predicted on the sole basis of epicardial flow analysis. | | | Although epicardial flow correlates with survival, recent studies have shown that further prognostic information is provided by the resolution of ST-segments on the electrocardiogram, a relatively simple marker of myocardial (i.e., microvascular) reperfusion. |
|
http://card.jwatch.org/cgi/content/full/2001/101/4
|
|
| Â Â |
| Â | Pharmacodynamic Profile of Short-term Abciximab Treatment Demonstrates Prolonged Platelet Inhibition With Gradual ... |
| | In flow cytometric assay (bottom), platelets were treated with same concentrations of unlabeled abciximab that was used for radiometric analysis. | | | PRP samples drawn before and at 3, 8, and 15 days after abciximab administration were treated with FITC-conjugated anti-abciximab reagent to detect platelet-bound abciximab, then analyzed by flow cytometry. | | | Graph represents corresponding molecules of abciximab bound per platelet plotted against median fluorescence channel numbers for three separate experiments. |
|
http://circ.ahajournals.org/cgi/content/full/97/17/1680
|
|
| Â Â |
| Â | Use of Abciximab during Infrainguinal Peripheral Vascular Interventions: Initial Experience -- Stavropoulos et al. 227 ... |
| | Use of Abciximab during Infrainguinal Peripheral Vascular Interventions: Initial Experience -- Stavropoulos et al. | | | Use of Abciximab during Infrainguinal Peripheral Vascular Interventions: Initial Experience | | | William Stavropoulos, MD Jeffrey A. Solomon, MD Michael C. Soulen, MD Timothy W. Clark, MD and Richard D. Shlansky-Goldberg, MD From the Department of Radiology, University of Pennsylvania Medical Center, 1 Silverstein, 3400 Spruce St, Philadelphia, PA 19010. |
|
http://radiology.rsnajnls.org/cgi/content/abstract/227/3/657
|
|
| Â Â |
| Â | Diabetics Undergoing Angioplasty Benefit From Antiplatelet Drug Reopro (Abciximab) |
| | Among all patients in the stent plus placebo group, 19 (2.4 percent) died at one year versus eight (1.0 percent) in the stent plus abciximab group, representing a 57 percent reduction in mortality. | | | Among this patient group, the risk of death or large, non-fatal heart attack (myocardial infarction) was reduced by 65 percent (14 percent to 4.9 percent). | | | For patients treated with stent and abciximab, mortality was significantly reduced, compared with patients treated with stent alone. |
|
http://www.docguide.com/dg.nsf/PrintPrint/BFE0FBC91EC1A94885256974004BF88D
|
|
| Â Â |
| Â | Writing Samples |
| | Risk of bleeding complications when abciximab used with thrombolytic therapy for PTCA (6/99) |
|
http://www.siricarpenter.com/writingsamples.htm
|
|
| Â Â |
| Â | Abciximab |
| | Abciximab is also contraindicated in patients with known hypersensitivity to any component of this product or to murine proteins. | | | Adjunct with heparin to prevent cardiac ischemic complications in those undergoing PCI; also, for unstable angina patients not responding to conventional therapy when PCI is scheduled within 24 hr. |
|
http://www.swemsed.com/Abciximab.htm
|
|
| Â Â |
| Â | MedlinePlus Medical Encyclopedia: Coronary heart disease |
| | Antithrombin drugs, such as blood-thinners (low-molecular heparin, unfractionated heparin), to reduce the risk of blood clots | | | Glycoprotein IIb-IIIa inhibitors, such as abciximab, eptifibatide, or tirofiban, to reduce the risk of blood clots | | | Antiplatelet agents, such as aspirin, ticlopidine, or clopidogrel, to reduce the risk of blood clots |
|
http://www.nlm.nih.gov/medlineplus/ency/article/007115.htm
|
|
| Â Â |
| Â | Reopro Online, Description, Chemistry, Ingredients - Abciximab - RxList Monographs |
| | RxList only refers patients to online pharmacies certified by VIPPS, Verified Internet Pharmacy Practice Sites, a program administered by the National Association of Boards of Pharmacy which ensures that member pharmacies offering online prescription services are bona fide, fully licensed, and demonstrate "competent Internet/interstate pharmacy practices." | | | Get the latest health information from leading experts, delivered direct to your email box! | | | Abciximab binds to the glycoprotein (GP) lIb/Ilia receptor of human platelets and inhibits platelet aggregation. |
|
http://www.rxlist.com/cgi/generic2/abcixim.htm
|
|
| Â Â |
| Â | NEJM -- Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of ... |
| | patients in the abciximab group (7.6 percent vs. 6.0 percent; | | | A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with Clopidogrel. | | | Merlini, P. A., Rossi, M., Menozzi, A., Buratti, S., Brennan, D. M., Moliterno, D. J., Topol, E. J., Ardissino, D. Thrombocytopenia Caused by Abciximab or Tirofiban and Its Association With Clinical Outcome in Patients Undergoing Coronary Stenting. |
|
http://content.nejm.org/cgi/content/abstract/344/25/1888
|
|
| Â Â |
| Â | A Collection of Word Oddities and Trivia |
| | Some others: ABCOULOMB, ABCHALAZAL, ABCAREE, CRABCAKE, DRABCLOTH, ABC SOIL, BABCOCK TEST, NABCHEAT, and ABCIXIMAB (a human-murine monoclonal antibody fragment that inhibits the aggregation of platelets) [Philip C. Bennett]. |
|
http://members.aol.com/gulfhigh2/words1.html
|
|
| Â Â |
| Â | pedoint |
| | par exemple: Stents & Abciximab: Current 'Treatment of Choice', Antibody Pro-drug for Solid Tumours, T-cell Depleted Allografting in NHL | | | Quelques articles sont accessibles avec Realplayer et l'anglais oral audible sur votre ordinateur, des exercices pour des étudiants? | | | Utiles pour leur contenu et pour la langue anglaise, audibles sur internet |
|
http://www.assim.refer.org/pedoint.htm
|
|
|
